Published in J Clin Invest on May 01, 1987
Human parvovirus B19. Clin Microbiol Rev (2002) 3.44
Pathogenesis of human parvovirus B19 in rheumatic disease. Ann Rheum Dis (2000) 1.82
A block in full-length transcript maturation in cells nonpermissive for B19 parvovirus. J Virol (1992) 1.48
Erythema infectiosum and pregnancy-related complications. CMAJ (1990) 1.40
Characterization of a nested polymerase chain reaction assay for detection of parvovirus B19. J Clin Microbiol (1993) 1.07
Severe leukopenia and dysregulated erythropoiesis in SCID mice persistently infected with the parvovirus minute virus of mice. J Virol (1999) 1.04
Parvovirus B19 infection in human pregnancy. BJOG (2010) 1.02
Experimental infection of cynomolgus monkeys with simian parvovirus. J Virol (1997) 0.98
Replication of parvovirus B19 in hematopoietic progenitor cells generated in vitro from normal human peripheral blood. J Virol (1992) 0.88
Blood Groups in Infection and Host Susceptibility. Clin Microbiol Rev (2015) 0.88
Myeloid depression follows infection of susceptible newborn mice with the parvovirus minute virus of mice (strain i). J Virol (1995) 0.87
Human Parvoviruses. Clin Microbiol Rev (2017) 0.84
The effects of co-infection with human parvovirus B19 and Plasmodium falciparum on type and degree of anaemia in Ghanaian children. Asian Pac J Trop Biomed (2013) 0.83
Human parvovirus B19 induced apoptotic bodies contain altered self-antigens that are phagocytosed by antigen presenting cells. PLoS One (2013) 0.79
Cynomolgus monkeys (Macaca fascicularis) experimentally infected with B19V and hepatitis A virus: no evidence of the co-infection as a cause of acute liver failure. Mem Inst Oswaldo Cruz (2016) 0.75
Preservative Monitoring of a Greek Woman with Hydrops Fetalis due to Parvovirus B19 Infection. Case Rep Obstet Gynecol (2017) 0.75
Parvovirus-like particles in human sera. Lancet (1975) 7.11
Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent. Lancet (1981) 4.62
Experimental parvoviral infection in humans. J Infect Dis (1985) 4.62
Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet (1981) 4.44
Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet (1983) 4.41
Human parvovirus-associated arthritis: a clinical and laboratory description. Lancet (1985) 3.82
A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature (1983) 3.02
Replication of the B19 parvovirus in human bone marrow cell cultures. Science (1986) 2.75
The development and use of an antibody capture radioimmunoassay for specific IgM to a human parvovirus-like agent. J Hyg (Lond) (1982) 2.09
Aplastic crisis due to parvovirus infection in pyruvate kinase deficiency. Lancet (1983) 2.05
Infection with parvovirus-like virus and aplastic crisis in chronic hemolytic anemia. Ann Intern Med (1983) 1.89
Characterization of a virus that causes transient aplastic crisis. J Clin Invest (1984) 1.78
Human serum "parvovirus": a specific cause of aplastic crisis in children with hereditary spherocytosis. J Pediatr (1983) 1.77
An erythema infectiosum-like illness caused by human parvovirus infection. N Engl J Med (1985) 1.77
Diagnosis of human parvovirus infection by dot-blot hybridization using cloned viral DNA. J Med Virol (1985) 1.55
The influence of culture conditions on the production of colony-stimulating activity by human placenta. Exp Hematol (1980) 1.39
Direct demonstration of the human parvovirus in erythroid progenitor cells infected in vitro. J Clin Invest (1984) 1.38
Analysis of Aleutian disease virus infection in vitro and in vivo: demonstration of Aleutian disease virus DNA in tissues of infected mink. J Virol (1985) 1.21
Immunoreactive erythropoietin in serum. I. Evidence for the validity of the assay method and the physiological relevance of estimates. Br J Haematol (1982) 1.19
Notions about human stem cells. Nouv Rev Fr Hematol Blood Cells (1976) 0.92
Human marrow erythropoiesis in culture: II. Heterogeneity in the morphology, time course of colony formation, and sedimentation velocities of the colony-forming cells. Am J Hematol (1977) 0.91
Improved culture of BFU-E and CFC-GM by the use of an oil seal. Br J Haematol (1983) 0.86
Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell (1999) 32.32
Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ (1995) 9.26
Psychological stress and susceptibility to the common cold. N Engl J Med (1991) 6.84
Itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother (1997) 4.75
A comparison of live and killed influenza-virus vaccines. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines. Lancet (1968) 4.66
Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent. Lancet (1981) 4.62
Experimental parvoviral infection in humans. J Infect Dis (1985) 4.62
Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet (1981) 4.44
Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet (1983) 4.41
Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell (1997) 4.38
Undescribed toxin in pseudomembranous colitis. Br Med J (1977) 4.31
Trials of Live Influenza Vaccine in the Royal Air Force. Br Med J (1962) 4.06
Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet (2005) 3.97
Inhibition of haemaggregation by lepromin and other mycobacterial substances. Nature (1967) 3.84
Work of a district ethical committee. Br Med J (1979) 3.64
Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age. Lancet (1992) 3.60
Nerve-induced and spontaneous redistribution of acetylcholine receptors on cultured muscle cells. J Physiol (1977) 3.45
Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis. Br Med J (1974) 3.42
An outbreak of erythema infectiosum associated with human parvovirus infection. J Hyg (Lond) (1984) 3.38
Simple, rapid method for assay of aminoglycoside antibiotics. Lancet (1971) 3.35
Letter: Viruses and gastroenteritis in infants. Lancet (1975) 3.13
The time course of the immune response to experimental coronavirus infection of man. Epidemiol Infect (1990) 3.12
The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med (1996) 3.10
Inhibition of respiratory virus infection by locally applied interferon. Lancet (1973) 3.02
Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol (1993) 3.01
Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature (1996) 2.95
Role of viruses in febrile convulsions. Arch Dis Child (1979) 2.72
Effects of innervation on the distribution of acetylcholine receptors on cultured muscle cells. J Physiol (1977) 2.71
Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines. J Hyg (Lond) (1971) 2.70
Investigetion into the attenuation of influenza viruses by serial passage. Br Med J (1968) 2.67
A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry (1988) 2.63
Immunogenicity and acceptability of a human diploid-cell culture rabies vaccine in volunteers. Lancet (1975) 2.61
Isolation of cDNA clones coding for the alpha-subunit of human beta-hexosaminidase. Extensive homology between the alpha- and beta-subunits and studies on Tay-Sachs disease. J Biol Chem (1986) 2.54
Human parvovirus B19. BMJ (1994) 2.53
The detection of specific IgM antibodies following infection with rubella virus. J Clin Pathol (1975) 2.49
Antiviral activity in milk of possible clinical importance. Lancet (1976) 2.47
Serological studies on infections by respiratory viruses of the inhabitants of Tristan da Cunha. J Hyg (Lond) (1967) 2.42
A respiratory virus study in Great Britain: review and evaluation. Prog Med Virol (1969) 2.34
A new virus cultivated only in organ cultures of human ciliated epithelium. Arch Gesamte Virusforsch (1966) 2.34
Common colds on Tristan da Cunha. J Hyg (Lond) (1971) 2.34
Rubella epidemiology in South East England. J Hyg (Lond) (1986) 2.28
New aspects of liposomes. Biochim Biophys Acta (1976) 2.27
A virus from epidemic vomiting disease. Br Med J (1972) 2.26
Organ cultures in virology. Prog Med Virol (1969) 2.21
Isolation of rhinoviruses and coronaviruses from 38 colds in adults. J Med Virol (1980) 2.21
Fluorescent staining of acetylcholine receptors in vertebrate skeletal muscle. J Physiol (1974) 2.20
Outcome of asymptomatic infection with rubella virus during pregnancy. J Hyg (Lond) (1981) 2.15
Improvements in a method of growing respiratory viruses in organ cultures. Br J Exp Pathol (1967) 2.13
Some improved techniques for the study of rhinoviruses using HeLa cells. Arch Gesamte Virusforsch (1968) 2.13
The development and use of an antibody capture radioimmunoassay for specific IgM to a human parvovirus-like agent. J Hyg (Lond) (1982) 2.09
The growth of some myxoviruses in organ cultures. Br J Exp Pathol (1965) 2.05
Coronaviridae: second report. Intervirology (1978) 2.05
The human parvovirus. Brief review. Arch Virol (1984) 2.05
Aplastic crisis due to parvovirus infection in pyruvate kinase deficiency. Lancet (1983) 2.05
Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Lancet (1986) 2.04
Cultivation of viruses from a high proportion of patients with colds. Lancet (1966) 2.04
The production of monoclonal antibodies to rubella haemagglutinin and their use in antibody-capture assays for rubella-specific IgM. J Hyg (Lond) (1982) 2.02
Live influenza B vaccine in volunteers. A report to the Medical Research Council by their Committee on Influenza and Other Respiratory Virus Vaccines. J Hyg (Lond) (1969) 2.02
Negative life events, perceived stress, negative affect, and susceptibility to the common cold. J Pers Soc Psychol (1993) 1.99
Effects of a "new" human respiratory virus in volunteers. Br Med J (1967) 1.98
The derivation of a minimum immune titre of rubella haemagglutination-inhibition (HI) antibody. A Public Health Laboratory Service collaborative survey. J Hyg (Lond) (1978) 1.96
Trial of ascorbic acid in prevention of colds. Br Med J (1967) 1.90
Infection with parvovirus-like virus and aplastic crisis in chronic hemolytic anemia. Ann Intern Med (1983) 1.89
An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study. Ann Oncol (2002) 1.87
Therapeutic implications of interaction of gentamicin and penicillins. Lancet (1971) 1.85
A year's experience of the rotavirus syndrome and its association with respiratory illness. Arch Dis Child (1979) 1.85
Experiments on the spread of colds. II. Studies in volunteers with coxsackievirus A21. J Hyg (Lond) (1965) 1.82
A comparative study of attenuated influenza viruses. Bull World Health Organ (1971) 1.81
An investigation of media for the long term storage of three respiratory viruses. Arch Gesamte Virusforsch (1974) 1.78
An erythema infectiosum-like illness caused by human parvovirus infection. N Engl J Med (1985) 1.77
Persistence of specific IgM after natural infection with rubella virus. Lancet (1975) 1.74
A simple, inexpensive gel filtration technique for use in diagnostic serology. J Clin Pathol (1973) 1.72
A comparison of three tests for rubella antibody screening. J Clin Pathol (1979) 1.71
Human parvovirus infection in homozygous sickle cell disease. Lancet (1993) 1.71
Serologically proved intrauterine infection with parvovirus. Br Med J (Clin Res Ed) (1984) 1.70
Toxicity of interferon. Br Med J (Clin Res Ed) (1981) 1.69
Useful laboratory measurements in the management of systemic lupus erythematosus. Q J Med (1982) 1.68
Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice. Nat Genet (1998) 1.68
The activity of enviroxime against rhinovirus infection in man. Lancet (1981) 1.66
Prevention of rhinovirus colds by human interferon alpha-2 from Escherichia coli. Lancet (1982) 1.66
Rapid assay of gentamicin. Lancet (1972) 1.64
Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines. J Hyg (Lond) (1977) 1.62
Adverse effects of intravenous immunoglobulin. Drug Saf (1993) 1.61
Aggregates of acetylcholine receptors are associated with plaques of a basal lamina heparan sulfate proteoglycan on the surface of skeletal muscle fibers. J Cell Biol (1983) 1.61
Chloroplast DNA inversions and the origin of the grass family (Poaceae). Proc Natl Acad Sci U S A (1992) 1.60
Further trials of live influenza vaccine. Br Med J (1966) 1.58
The morphology of three previously uncharacterized human respiratory viruses that grow in organ culture. J Gen Virol (1967) 1.58
Cultivation of "difficult" viruses from patients with common colds. Br Med J (1968) 1.57
Comparison of immunofluorescence and radioimmunoassay for detecting IgM antibody in infants with the congenital rubella syndrome. J Hyg (Lond) (1979) 1.57